These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 380077

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Ia versus K/D antigens in immunological enhancement of tumour allografts. II. Studies with alloimmune sera prepared in recombinant strains.
    Duc HT, Kinsky RG, Voisin GA.
    Ann Immunol (Paris); 1979; 130C(3):461-74. PubMed ID: 475347
    [Abstract] [Full Text] [Related]

  • 4. The dominant role of Ia antibodies in the passive enhancement of H-2 incompatible skin grafts.
    Staines NA, Guy K, Davies DA.
    Eur J Immunol; 1975 Nov; 5(11):782-9. PubMed ID: 802473
    [Abstract] [Full Text] [Related]

  • 5. Regulation of transplantation immunity in vivo by monoclonal antibodies recognizing host class II restriction elements. I. Genetics and specificity of anti-Ia immunotherapy in murine skin allograft recipients.
    Perry LL, Williams IR.
    J Immunol; 1985 May; 134(5):2935-41. PubMed ID: 2580008
    [Abstract] [Full Text] [Related]

  • 6. Murine IgA binding factors (IgA-BF) suppressing IgA production: characterization and target specificity of IgA-BF.
    Noro N, Adachi M, Yasuda K, Masuda T, Yodoi J.
    J Immunol; 1986 Apr 15; 136(8):2910-6. PubMed ID: 3514749
    [Abstract] [Full Text] [Related]

  • 7. Isolation of pure IgG subclasses from mouse alloantiserum and their activity in enhancement and hyperacute rejection of skin allografts.
    Jansen JL, Gerard AP, Kamp J, Tamboer WP, Wijdeveld PG.
    J Immunol; 1975 Aug 15; 115(2):387-91. PubMed ID: 807636
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evidence for homologues of the murine I-A and I-E loci in the rat MHC.
    Shinohara N, Sachs DH.
    J Immunol; 1981 Mar 15; 126(3):934-7. PubMed ID: 6970226
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
    Peeler JS, Niederkorn JY.
    J Immunol; 1986 Jun 15; 136(12):4362-71. PubMed ID: 3519767
    [Abstract] [Full Text] [Related]

  • 19. Detection of at least two distinct mouse I-E antigen molecules by the use of a monoclonal antibody.
    Ozato K, Sachs DH.
    J Immunol; 1982 Feb 15; 128(2):807-10. PubMed ID: 6948041
    [Abstract] [Full Text] [Related]

  • 20. High frequency of splenic anti-class I cytotoxic T lymphocyte precursors correlates with in vivo rejection of K/D region disparate thyroid and islet grafts in mice.
    Isakov N, Bach FH.
    J Immunol; 1984 Jan 15; 132(1):50-6. PubMed ID: 6418804
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.